Diagnostic and prognostic value of antibodies to cyclic citrullinated peptide (Anti-CCP) in rheumatoid arthritis;Il significato diagnostico, e prognostico degli anticorpi anti-peptide citrullinato ciclico (Anti-CCP) nell'artrite reumatoide

Reumatismo

Volumn 56, Issue 2, 2004, Pages 118-123

  Erre, Gian Luca ^a,b   Tocco, A ^a   Faedda, R ^a   Cossu, A ^a   Carcassi, A ^a  

^a UNIVERSITY OF SASSARI   (Italy)

^b Cattedra e Sc di Spec di Reumatol   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CITRULLINE; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; FILAGGRIN; PEPTIDE ANTIBODY; UNCLASSIFIED DRUG;

DIAGNOSTIC VALUE; DISEASE DURATION; EARLY DIAGNOSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; PREVALENCE; PROGNOSIS; REVIEW; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SYNOVIAL FLUID;

ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; INTERMEDIATE FILAMENT PROTEINS; PEPTIDES, CYCLIC; PREVALENCE; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SYNOVIAL FLUID; TIME FACTORS;

EID: 3142720470     PISSN: 00487449     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (32)

1. Nienhuis RLF, Mandema EA. A new serum factor in patients with rheumatoid arthritis. The Antiperinuclear factor. Ann Rheum Dis 1964; 23: 302-5.
2. Hoet RM, van Venrooij WJ. The antiperinuclear factor (APF) and antikeratin antibodies (AKA) in rheumatoid arthritis. In: Smolen JS, Kalden JR, Maini RN, eds. Rheumatoid arthritis. Berlin, Heidelberg: Springer 1992: 299-318.
3. Young BJJ, Mallya RK, Leslie RDG, Clark CJM, Hamblin TJ. Anti-keratin antibodies in rheumatoid arthritis. Br Med J 1979; 2: 97-9.
4. Goldbach-Mansky R, Lee J, Hoxworth J, Yarboro C, Smolen JS, Steiner G, et al. Rheumatoid arthritis associated autoantibodies in patients with sinovitis of recent onset. Arthritis Res 2000; 2: 236-43.
5. Sebbag M, Simon M, Vincent C, Masson-Bessière, Girbal E, Durieux JJ, et al. The Antiperinuclear factor and the so called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J Clin Invest 1995; 95: 2672-9.
6. Dale BA, Resing KA, Haydock PV, Fillaggrins. In cellular and molecular biology of intermediate filaments. Goldman RD, Steinert Pm, editors, Plenum Publishing Corporation, New Jork/London 1992; 393-412.
7. Schellekens GA, De Jong BAW, Van de Hoogen FHJ, Van de Putte LBA, Van Venrooij WJ. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998; 101: 273-7.
8. Vossenaar ER, Nijenhuis S, Helsen MMA, Van der Heijden A, Senshu T, Ven de Berg WB, et al. Citrullination of synovial proteins in murine models of rheumatoid arthritis. Arthritis Rheum 2003; 48: 2489-500.
9. Baeten D, Peene I, Union A, Sebbag M, Serre G, Veys EM, et al. Specific presence of intracellular citrullinate proteins in rheumatoid arthritis synovium: relevance to antifilaggrin autoantibodies. Arthritis Rheum 2001; 44: 2218-62.
10. Masson-Bessière C, Sebbag M, Girbal-Neuhauser E, Nogueira L, Vincent C, Senshu T, et al. The major synovial targets of rheumatoid arthritis-specific antifillagrin autoantibodies are deiminated forms of the ?- and β-chains of fibrin. J Immunol 2001; 166: 4177-84.
11. Masson-Bessière C, Sebbag M, Durieux JJ, Nogueira L, Vincent C, Girbal-Neuhauser E, et al. In the rheumatoid pannus, antifillagrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum. Clin Exp Immunol 2000; 119: 544-52.
12. Utz PJ, Hottelet M, Schur PH, Anderson P. Proteins phosphorilated during stress-induced apoptosis are common targets for autoantibody production in patients with systemic lupus erythematosus. J Exp Med 1997; 185: 843-54.
13. Casciola-Rosen LA, Anhalt G, Rosen A. Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface blebs on cultured keratinocytes. J Exp Med 1994; 179: 1317-30.
14. Asaga H, Yamada M, Senshu T. Selective deimination of vimentin in calcium ionophore-induced apoptosis of mouse peritoneal macrophages. Biochem Biophis Res Commun 1998; 243: 641-6.
15. Suzuki K, Sawada T, Murakami A, Matsui T, Tohma S, Nakazono K, et al. High diagnostic performance of Elisa detection of antibodies to citrullinated antigens in rheumatoid arthritis. Scand J Rheumatol 2003; 32: 197-204.
16. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Reum 1988; 31: 315-24.
17. Bizzaro N, Mazzanti G, Tonutti E, Villalta D, Tozzoli R. Diagnostic accuracy of Anti-citrulline antiboidy assay for rheumatoid arthritis. Clinical Chemistry 2001; 47: 1089-93.
18. Schellekens GA, Visser H, De Jong BA, Van de Hoogen FH, Hazes JM, Breedveld FC, et al, The diagnostic properties of rheumatoid arthritis recognizing a cyclic citrullinated peptide. Arthritis Rheum 2000; 43: 155-63.
19. Nogueira L, Chapuy-Regaud S, Constantin A. Autoantibodies to deiminated fibrinogenare the most efficient serological criterion for early rheumatoid arthritis diagnosis. Arthritis Res Ther 2003; 5 (Suppl 1): S6.
20. Saraux A, Berthelot JM, Devauchelle V, Bendaoud B, Chales G, Le Henaff C, et al. Value of Antibodies to Citrulline-Containing Peptides for diagnosing early rheumatoid arthritis. J Rheumatol 2003; 30: 2535-39.
21. Kroot EJ, De Jong BA, Van Leeuwen MA, Swinkels H, Van den Hoogen FH, Van't Hof M, et al. The prognostic value of anti-cyclic citrullinate peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 2000; 43: 1831-5.
22. Goldbach-Mansky R, Lee J, Hoxworth J, Yarboro C, Smolen JS, Steiner G, et al. Rheumatoid arthritis associated autoantibodies in patients with sinovitis of recent onset. Arthritis Res 2000; 2: 236-43.
23. Jansen LMA, van Schaardenburg D, van der Horst-Bruinsma IE, van de Stadt RJ, de Koning MHMT, Dijkmans BAC. The predictive value of Anti-Cyclic citrullinated peptide antibodies in early arthritis. J Rheumatol 203; 30: 1961-5.
24. Nell VPK, Machold KP, Eberl G, Hiesberger H, Hoefler E, Smolen JS, et al. The diagnostic and prognostic significance of autoantibodies in patients with very early arthritis. Arthritis Rheum 2003; 48 (9 Suppl): 107S.
25. Visser H, Le Cessie S, Vos K, Breedveld FC, Hazes JM. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 2002; 46: 357-65.
26. Rantapaa-Dahlqvist S, de Jong BAW, Berglin E, Hallmans G, Wadell G, Stenlund H, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predicti the development of rheumatoid arthritis. Arthritis Rheum 2003; 48: 2741-9.
27. Jansen LMA, van der Horst-Bruinsma IE, van Schaardenburg D, van de Stadt RJ, de Koning MHMT, Dukmans BAC. Rheumatoid factor and antibodies to cyclic citrullinated peptide differentiate rheumatoid arthritis from undifferentiated polyarthritis in patients with early arthritis. J Rheumatol 2002; 29: 207-6
28. Meyer O, Combe B, Elias A, Benali K, Clot J, Sany J, et al. Autoantibodies predicting the outcome of rheumatoid arthritis: evaluation in two subsets of patients according to severity of radiographic damage. Ann Rheum Dis 1997; 56: 682-5.
29. Xia Ofeng Zeng, Maixing AI, Xinping Tian, Xiaodan Gang, Yanping Shi, Qinfang Song et al. Diagnostic value of anti-cyclic citrullinated peptide antibody in patientswith rheumatoid arthritis. J Rheum 2003; 30: 1451-5.
30. Wolfe F, Sharp JT. Radiographic outcome of recent onset rheumatoid arthritis. Arthritis Rheum 1998; 41: 1571-82.
31. Erre GL, Tocco A, Fenu P, Dellacà P, Lepori G, Sanna M, et al. Utilità del dosaggio degli Anticorpi anti-cheratina e anti-peptide citrullinato ciclico nel follow-up dei pazienti con artrite reumatoide. Reumatismo 2003; 55 (Suppl 5): 23.
32. Van Jaarsveld CHM, der Borg EJ, Jacobs JWG, Schellekens GA, Gmelig-Meyling FHJ, van Booma-Frankfort C, et al. The prognostic vaue of the antiperinuclear factor, anti-citrullinate antibodies and rheumatoid factor in early rheimatoid arthritis. Clin Exp Rheumatol 1999; 17: 689-97.